Alexander Hardy
President and CEO
Replay available
BioMarin Pharmaceutical Inc. (BMRN) Q3 2025 Earnings Call
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Q3 2025 earnings conference call, held 2025-10-27. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Brian Mueller
Chief Financial Officer
Kristen Hubbard
Chief Commercial Officer
Greg Freiberg
Chief R&D Officer
Phil Nadeau
Analyst, TD Cowen
Selvine Richter
Analyst, Goldman Sachs
Corey Kasimov
Analyst, Evercore
Chris Raymond
Analyst, Raymond James
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Biomarin Pharmaceutical Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.297 commercial products, and potential future products in different areas of therapeutic 00:00:04.297 -- 00:00:09.063 research and development. Results may differ materially depending on the progress of 00:00:09.063 -- 00:00:14.270 Biomarin's product programs, actions of regulatory authorities, availability 00:00:14.270 -- 00:00:19.316 of capital, future actions in the pharmaceutical market, and developments by competitors. 00:00:19.316 -- 00:00:24.363 And those factors detailed in Biomarin's filings with the Securities and Exchange Commission, 00:00:24.363 -- 00:00:29.479 such as 10Q, 10K, and 8K reports. In addition, we will 00:00:29.479 -- 00:00:34.826 use non-GAAP financial metrics as defined in Regulation G during the call today. 00:00:34.826 -- 00:00:40.193 These non-GAAP measures should not be considered in isolation from, as substitutes for, 00:00:40.193 -- 00:00:44.019 or superior to financial measures prepared in accordance with U.S. 00:00:44.019 -- 00:00:47.724 GAAP, and you can find the related reconciliations to U.S. 00:00:47.724 -- 00:00:52.891 GAAP in the earnings release and earnings presentation, both of which are available 00:00:52.891 -- 00:00:56.309 in the investor relations section of our website. 00:00:56.309 -- 00:01:01.194 Please note that our commentary on today's call will focus on non-GAAP financial measures 00:01:01.194 -- 00:01:04.035 unless otherwise indicated. 00:01:04.137 -- 00:01:09.642 Beginning on slide three and introducing Biomarin's management team joining today's call, 00:01:09.642 -- 00:01:14.767 Alexander Hardy, President and Chief Executive Officer, Brian Mueller, Chief Financial 00:01:14.767 -- 00:01:20.793 Officer, Kristen Hubbard, Chief Commercial Officer, and Greg Freiberg, Chief R&D Office...